NL-OMON47823已完成不适用
OPTI-CLOT: Peri-OPerative pharmacokineTIc-guided dosing of CLOTting factor in hemophilia - OPTI-CLOT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 99（—）
入选标准
- •- Severe and moderate hemophilia A (FVIII plasma level *5%)
- •- Elective and low or medium risk surgery as defined by surgical risk score
- •- * 12 years of age at inclusion date for the randomized controlled trial
- •- <12 years of age at inclusion date for the PK-guided dosing observational
- •children cohort
- •- Written informed consent.
排除标准
- •- Patients with other congenital or acquired hemostatic abnormalities.
- •- Withdrawal of (parental) informed consent.
- •- Detectable FVIII inhibiting antibodies (>0,2 BU) at inclusion in study.
- •- General medical conditions which may interfere with participation in the
研究者
相似试验
进行中（未招募）
1 期
Study of Pharmacokinetic-guided dosing of clottiing factor in Hemophilia.HemophilliaMedDRA version: 20.0Level: LLTClassification code 10066439Term: HemophiliaSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10060614Term: Hemophilia B (Factor IX)System Organ Class: 100000004850EUCTR2013-000909-24-NLErasmus MC72
已完成
3 期
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the EsophagusEsophageal Adenocarcinoma (UICC TNM7)Adenocarcinoma of the Esophagogastric JunctionC15Malignant neoplasm of oesophagusDRKS00008008niversity Hospital Schleswig-Holstein438
进行中（未招募）
1 期
Perioperative Chemotherapy (FLOT Protocol) Compared To Neoadjuvant Chemoradiation (CROSS Protocol) in Patients With Adenocarcinoma of the Esophagus - ESOPECHistologically proven adenocarcinoma of the esophagus according to the Union internationale contre le cancer (UICC) TNM7 definition. Both tumors of the esophagus and tumors of which the epicentre is within 5 cm of the esophagogastric junction and also extend into the esophagus can be included into the trial in case of adenocarcinomatous histology.MedDRA version: 21.1Level: LLTClassification code 10026180Term: Malignant neoplasm of oesophagusSystem Organ Class: 100000004864EUCTR2015-001683-20-DEniversitätsklinikum Schleswig-Holstein, Campus Lübeck438
已完成
不适用
Peri -and postoperative drug therapy schedules for morbidly obese patientsmorbide obesitasextreme obesityMorbid obesityNL-OMON33325Sint Antonius Ziekenhuis20
招募中
3 期
Various types of meropenem administration in patients with VAP snd ARCIRCT20130917014693N12Shahid Beheshti University of Medical Sciences60